Leena Das-Young

General Manager and Chief Lunar Officer

Guardant Health

Dr Leena Das-Young is the General Manager and Chief Lunar Officer at Guardant Health responsible for the end-to-end oversight of all work applying Guardant Health’s technology and database of more than 100,000 clinical Guardant360 assay toward new applications in early-stage cancer (LUNAR) such as residual disease detection, recurrence monitoring and early detection of cancer. Previously, she was most recently the Vice President & Head of the Late Phase Strategy and Development Group in Pfizer in the Oncology group and was responsible for a portfolio of oncology programs programs including Ibrance, Xalkori, Talzenna, Besponsa, Sutent, Iorlatinib, and others. Prior to her roles in product development, she served in increasingly senior commercial roles responsible for several successful launches in both Pfizer and Bayer. She received her BS and Doctor of Pharmacy degrees from Purdue University.